Find cutting edge cancer clinical trials near you using the new Victorian Cancer Trials Link.

Search now

Abrevio project

The Abrevio project aims to improve the efficiency of processing cancer notifications using AI technology, support the expansion of the VCR dataset and, replace aging infrastructure and databases.

Project background

In January 2019, the Victorian Department of Health and Human Services provided funding to implement a customised version of the Abrevio tumour abstracting system.

The Abrevio system is the companion product to the E-Path system implemented by VCR at most pathology laboratories to report electronic cancer pathology to the VCR in near real-time.

Explaining Abrevio

Abrevio is a document processing system that consolidates electronic medical reports from various sources and links them to patient cases of primary tumours. For the VCR this will allow automatic consolidation of all electronic cancer notifications from hospitals, screening registers, radiotherapy centres and pathology laboratories. 

In addition, Abrevio has artificial intelligence (AI) capability and can automatically extract data elements and auto-populate forms with extracted discrete data elements from pathology reports. It also has an additional feature that can pre-screen patients for clinical trials and research studies. 

VCR and Abrevio

Abrevio will streamline existing work processes to manage the increasing volume of cancer notifications and support the continued timeliness of cancer incidence and mortality statistics in Victoria. For the 2018 incidence year statistics, the VCR processed more than 164,000 source records.  

Abrevio will also support future expansion of the existing VCR dataset in-line with integrated cancer diagnostic practises, clinical demands (staging) and changes to coding classifications.

The Abrevio project is anticipated to go live in August 2020.

Contact details

Fiona Kennett
E-Path Project Coordinator
fiona.kennett@cancervic.org.au
 

If you'd like to know more about the VCR, you can speak to us directly.

Contact us